Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab vs ibandronate in postmenopausal women sub-optimally treated with bisphosphonates
2009-010726-19Phase 3Completed
- Sponsor
- Amgen
- Start
- Jul 2009
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in osteoporosis comparing Denosumab arm with Ibandronate arm (2 arms). Primary endpoint: Primary: Percent change from baseline in BMD at the total hip at 12 months. Started Jul 2009; status: completed.
02
Drugs
denosumabibandronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2009-010726-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010726-19.